Keywords: Non
Hodgkin Lymphoma, Mercury, EMF Radiation, Retroocular Tumor, Axilia, Lung, Infections,
Hickman Catheter, Hyperbatic Oxygen, Chemotherapy, Moribund, Cardiac Insufficiency. Case: Non Hodgkin Lymphoma Condition: Superior
Vena Cava Syndrome
A NON HODGKIN LYMPHOMA CANCER PATIENT AN UNFINISHED TREATMENT WITH PAPIMI AND ITS UNFORTUNATE CONCLUSION Discharge Summary From Tijuana Mexico by The
Patient's Personal (Hospital's) Attending M.D. June 25, 2000 The patient was a 64-year old
Caucasian male with the diagnosis of a Non Hodgkin Lymphoma diagnosed in 1994. The patient
was an electrical engineer who was exposed to high levels of lead, mercury and EMF
radiation. The patient initiated with a
retroocular tumor of the right eye, which later metastasized to the base of the right side
of the neck, right axilla, and the lung field. Although the large tumors had disappeared
while interned at his facility in 1998, the right retroocular tumor had not disappeared.
It was recommended that the patient return for treatment in 1999 to this Hospital. February of 1999, recurrent
secondary infections, a depressed immune system with high levels of toxicity from mercury,
lead, arsenic, aluminum, cobalt, etc., in conjunction with a long standing Hickman
catheter with a probable infection resulted in tumor growth and the presence of a superior
vena cava syndrome. The patient finally acceded to
assessment with a CT scan of the thorax and neck, as well as use of Hyperbatic Oxygen
Therapy, parenteral nutrition, packed red blood cells, and fresh frozen plasma with close
monitorization of this condition. Hemato-Oncology reviewed the case, and considered the
patient an excellent candidate for chemotherapy, explaining that he was virgin to the
treatment and would have a good response. Unfortunately, at two weeks from the time of
administration of the chemotherapy (CHOMP) the patient did not have any response in tumor
regression as seen by subsequent scans. His energy levels were minimal, and the patient
considered moribund and clinically unstable. February 18, 2000, under
medical and nursing supervision, the patient was decided to be transported to Dr. Gloria
G. nearby office-clinic for evaluation and treatment with the PAP IMI device that it was
there. Due to his critical status, it was required to send the patient daily by wheel
chair, with extended medical support for each treatment. The patient was initially not
considered to survive the first weekend, however, the patient began to have a daily
improvement with PAPIMI treatments. The patient underwent 28 treatments between February
18, 2000 and April 25, 2000, noting almost a spectacular and complete reduction of the
tumor masses during this period of time. Subsequent scans corroborated the clinical
picture of change from a superior vena cava syndrome, to disappearance of clinical signs
of tumors. Unfortunately, in one of my
longer absence from the ... Hospital, it was decided to suspend the PAPIMI treatments, and
two subsequent treatments with chemotherapy were decided instead, and were administered
with deleterious results. The patient ultimately succumbed to a cardiac insufficiency with
a superior vena cava syndrome from tumoral compression on June 18, 2000 The Patient's Personal M.D. |
